AI assistant
Sending…
Precipio, Inc. — Director's Dealing 2014
May 16, 2014
34807_dirs_2014-05-16_be3bc379-6a9c-4048-be7d-e4cc8bd2a9cd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TRANSGENOMIC INC (TBIO)
CIK: 0001043961
Period of Report: 2014-05-14
Reporting Person: THOMPSON JOHN D (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-05-14 | Stock Option (Right to Buy) | $4.14 | A | 5000 | Acquired | 2024-05-13 | Common Stock (5000) | Direct |
| 2014-05-14 | Stock Option (Right to Buy) | $4.14 | G | 5000 | Disposed | 2024-05-13 | Common Stock (5000) | Direct |
| 2014-05-14 | Stock Option (Right to Buy) | $4.14 | G | 5000 | Acquired | 2024-05-13 | Common Stock (5000) | Indirect |
Footnotes
F1: Common Stock, par value $.01 per share of Transgenomic, Inc.
F2: Immediately following the grant of the option reported in the first line of Table II, the option was transferred from the reporting person to a family trust for which the reporting person is a trustee.
More from Precipio, Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 6
Earnings Release
2026
Feb 27
Major Shareholding Notification
2026
Feb 10
Regulatory Filings
2026
Jan 26
Director's Dealing
2026
Jan 20
Director's Dealing
2026
Jan 20
Director's Dealing
2026
Jan 20
Director's Dealing
2026
Jan 20
Director's Dealing
2026
Jan 20